pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
789
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
NVK-029
Presbyopia
Vyluma Inc
0
catalysts
Phase 1
NVK-031
Unspecified Ophthalmological Disorders
Vyluma Inc
0
catalysts
Phase 1
NX-1607
Adenocarcinoma Of The Gastroesophageal Junction
$NRIX
Nurix Therapeutics, Inc.
0
catalysts
Phase 1
← prev
page 16 of 27
next →
131
Pain
89
Neurology
1
NXP-900
Cervical Cancer
$NVCT
Nuvectis Pharma, Inc.
0
catalysts
Phase 1
Nezavist
Alcohol Use Disorder (AUD)
Lohocla Research Corp
0
catalysts
Phase 1
OCF-001
Vulvovaginal Candidiasis
Sano Chemicals Inc
0
catalysts
Phase 1
OCU-200
Diabetic Macular Edema
$OCGN
Ocugen, Inc.
0
catalysts
Phase 1
OLANZAPINE
OLANZAPINE (OLANZAPINE)
1 INDICATIONS AND USAGE Olanzapine is an atypical antipsychotic indicated: As…
D2-like dopamine receptor
5-hydroxytryptamine receptor 2C
$RDY
DR REDDYS LABORATORIES LTD
0
catalysts
Phase 1
OLX-07010
Alzheimer's Disease
Oligomerix inc
0
catalysts
Phase 1
OLX-301A
Dry (Atrophic) Macular Degeneration
Laboratoires Thea SA
0
catalysts
Phase 1
OMS-527
Substance (Drug) Abuse
$OMER
OMEROS CORP
0
catalysts
Phase 1
ONO-2910
Diabetic Neuropathy
Ono Pharmaceutical Co Ltd
0
catalysts
Phase 1
OP-3136
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$OLMA
Olema Pharmaceuticals, Inc.
0
catalysts
Phase 1
OPC-214870
Epilepsy
Otsuka Pharmaceutical Co Ltd
0
catalysts
Phase 1
OPL-009
Hypertension
Overseas Pharmaceuticals Ltd
0
catalysts
Phase 1
OPN-6602
Refractory Multiple Myeloma
Opna Bio SA
0
catalysts
Phase 1
OTOV-101
Deafness
Suzhou Otovia Therapeutics Co Ltd
0
catalysts
Phase 1
OTS-167
Metastatic Breast Cancer
OncoTherapy Science Inc
0
catalysts
Phase 1
OV-329
Seizures
$OVID
Ovid Therapeutics Inc.
0
catalysts
Phase 1
Oncoquest
Chronic Lymphocytic Leukemia (CLL)
XEME BioPharma Inc
0
catalysts
Phase 1
P-01
Pancreatic Cancer
Hangzhou Neoantigen Therapeutics Co Ltd
0
catalysts
Phase 1
PA-001
Coronavirus Disease 2019 (COVID-19)
PeptiAID Inc
0
catalysts
Phase 1
PAS-004
Plexiform Neurofibroma
$KTTA
Pasithea Therapeutics Corp.
0
catalysts
Phase 1
PBCAR-19B
Diffuse Large B-Cell Lymphoma
$DTIL
PRECISION BIOSCIENCES INC
0
catalysts
Phase 1
PBXCT-02
Bladder Cancer
Celltrion Inc
0
catalysts
Phase 1
PCNAT-01
Pancreatic Ductal Adenocarcinoma
Anda Biopharmaceutical Development (Shenzhen) Co Ltd
0
catalysts
Phase 1
PF-07832837
Atopic Dermatitis (Atopic Eczema)
$PFE
PFIZER INC
0
catalysts
Phase 1
PF-08046052
Head And Neck Squamous Cell Carcinoma (HNSC)
$PFE
PFIZER INC
0
catalysts
Phase 1
PF-08052666
Endometrial Cancer
$PFE
PFIZER INC
0
catalysts
Phase 1
PF614-MPAR
Pain
$ENSC
Ensysce Biosciences, Inc.
0
catalysts
